Embryo Health Study
The Embryo Health Study: Prospective Longitudinal Analysis of PGT-P
Genomic Prediction Inc.
500 participants
Dec 1, 2020
OBSERVATIONAL
Conditions
Summary
This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.
Eligibility
Inclusion Criteria1
- All couples of Caucasian or East Asian ancestry above the age of 18 who elect to have PGT-A as part of their IVF treatment cycle.
Exclusion Criteria2
- Any case where biological parental DNA is unavailable.
- Any case involving PGT-M or PGT-SR.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Embryo biopsies will undergo preimplantation genetic testing for aneuploidies as per standard of care, and polygenic disease risk (PGT-P) will be computed for these samples.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04528498